Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
FLOW trial
Description:
A randomized clinical trial evaluating semaglutide in people with type 2 diabetes and chronic kidney disease.
Primary topic:
Diabetes Treatment and Management (47%)
Related topics:
Diabetes Treatment and Management (47%),
Chronic Kidney Disease and Diabetes (31%),
Bone fractures and treatments (9%)
OpenAlex ID:
keywords/flow-trial
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
2023
·
Peter Rossing
, Florian M M Baeres
, et al.
·
Nephrology Dialysis Transplantation
·
265
PDF
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024
·
Johannes F. E. Mann
, Peter Rossing
, et al.
·
Nature Medicine
·
244
PDF
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials
2025
·
Matthew M.Y. Lee
, Naveed Sattar
, et al.
·
Diabetes Care
·
181
PDF
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
2024
·
Richard E. Pratley
, Katherine R. Tuttle
, et al.
·
Journal of the American College of Cardiology
·
159
PDF
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Kidney Disease: Evolving Evidence and Clinical Application
2025
·
Jae Hyun Bae
·
Diabetes & Metabolism Journal
·
102
PDF
Predicting and Preventing Loss to Follow-up of Adult Trauma Patients in Randomized Controlled Trials: An Example from the FLOW Trial
2017
·
Kim Madden
, Taryn Scott
, et al.
·
Journal of Bone and Joint Surgery
·
81
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trial
2024
·
Kenneth W Mahaffey
, Katherine R Tuttle
, et al.
·
European Heart Journal
·
78
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
2020
·
Charlotte M. Mosterd
, Petter Bjornstad
, et al.
·
Journal of Nephrology
·
64
PDF
FLOW trial stopped early due to evidence of renal protection with semaglutide
2023
·
Felice Gragnano
, Vincenzo De Sio
, et al.
·
European Heart Journal - Cardiovascular Pharmacotherapy
·
56
PDF
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists
2025
·
J Chen
, ME Cooper
, et al.
·
Diabetes & Metabolism
·
35
A Machine Learning Algorithm to Identify Patients with Tibial Shaft Fractures at Risk for Infection After Operative Treatment
2020
·
Machine Learning Consortium, on behalf of the SPRINT and FLOW Investigators
·
Journal of Bone and Joint Surgery
·
33
Glucagon‐like peptide‐1 receptor agonists and kidney outcomes
2024
·
Richard J. MacIsaac
, Philippa Trevella
, et al.
·
Journal of Diabetes
·
31
PDF
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome
2025
·
Richard J MacIsaac
·
Future Cardiology
·
30
Association of Three-Month Radiographic Union Score for Tibia Fractures (RUST) with Nonunion in Tibial Shaft Fracture Patients
2020
·
Raman Mundi
, Daniel Axelrod
, et al.
·
Cureus
·
29
PDF
Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis
2025
·
Peter Rossing
, George Bakris
, et al.
·
Diabetes Care
·
28
PDF
Potential kidney protective effects of glucagon‐like peptide‐1 receptor agonists
2024
·
Philippa Trevella
, Elif I. Ekinci
, et al.
·
Nephrology
·
27
Glucagon-like Peptide-1 Receptor Agonists: New Evidence of Kidney and Cardiovascular Protection From the FLOW and SELECT Trials
2024
·
Maarten W. Taal
, Nicholas M. Selby
·
American Journal of Kidney Diseases
·
26
PDF
Upcoming drug targets for kidney protective effects in chronic kidney disease
2025
·
Massimo Nardone
, Kevin Yau
, et al.
·
Nephrology Dialysis Transplantation
·
25
PDF
Effect of Extended Prophylactic Antibiotic Duration in the Treatment of Open Fracture Wounds Differs by Level of Contamination
2020
·
Christina A. Stennett
, Nathan N. O'Hara
, et al.
·
Journal of Orthopaedic Trauma
·
24
Infection and Nonunion Rates in Open Fractures: Description of 6,042 Fractures from the FLOW and PREP-IT Trials
2025
·
Roman M. Natoli
, Lucas S. Marchand
, et al.
·
Journal of Bone and Joint Surgery
·
23
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials
2024
·
Luís Mendonça
, Henrique Moura
, et al.
·
Clinical Journal of the American Society of Nephrology
·
22
Diretriz da Sociedade Brasileira de Diabetes
2024
·
Marcello Casaccia Bertoluci
, Adriana Costa Forti
, et al.
·
Conectando Pessoas eBooks
·
22
Deficits in preference-based health-related quality of life after complications associated with tibial fracture
2018
·
I. L. Gitajn
, A. J. Titus
, et al.
·
The Bone & Joint Journal
·
22
Efficacy of glucagon-like peptide-1 receptor agonists for prevention of stroke among patients with and without diabetes: A meta-analysis with the SELECT and FLOW trails
2025
·
Asmita Gera
, Fakhar Latif
, et al.
·
IJC Heart & Vasculature
·
19
Wound Irrigation in Initial Management of Open Fractures
2016
·
Sendi, Parham
, McNally, Martin A
·
New England Journal of Medicine
·
18
Show more works
View as search
Works count:
162
Citation count:
1,894
Year
Topic
Type